A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-6345 in Healthy Subjects

NCT03809039 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

52

Enrollment

INDUSTRY

Sponsor class

Stopped Preclinical finding

Conditions

Healthy

Interventions

DRUG: MT-6345
DRUG: MT-6345 Placebo

Sponsor

Tanabe Pharma America, Inc.